Rationale and Challenges for a New Instrument for Remote Measurement of Negative Symptoms
David G. Daniel, Stephen R. Marder(West Los Angeles College), Alex S. Cohen(Louisiana State University), Raeanne C. Moore(University of California San Diego), Philip D. Harvey(University of Miami), Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), William Z. Potter(National Heart Lung and Blood Institute), William P. Horan(Neurobehavioral Systems)
Cited by 3
Related Papers
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832
Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia
|Human Brain Mapping|2005|622
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
|PubMed|2009|611
Acetaminophen‐induced hepatic injury: Protective role of glutathione in man and rationale for therapy
|Clinical Pharmacology & Therapeutics|1974|533
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
|Patient Preference and Adherence|2017|325